Karolinska Development’S Portfolio Company Umecrine Cognition Presents New Preclinical Parkinson’S Data On Golexanolone At The Scientific Conference, INBC 2024

(MENAFN - GlobeNewsWire - Nasdaq) STOCKHOLM, SWEDEN – October 17, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition will present ...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute